Enzo Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Enzo Biochem
ENZ Stock  USD 0.49  0.01  2.76%   
Enzo Biochem financial statements provide useful quarterly and yearly information to potential Enzo Biochem investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Enzo Biochem financial statements helps investors assess Enzo Biochem's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Enzo Biochem's valuation are summarized below:
Gross Profit
13.5 M
Profit Margin
(0.75)
Market Capitalization
26.1 M
Enterprise Value Revenue
0.2629
Revenue
30.3 M
We have found one hundred twenty available fundamental signals for Enzo Biochem, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Enzo Biochem prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 49.6 M in 2025. Enterprise Value is likely to drop to about 7.8 M in 2025

Enzo Biochem Total Revenue

63.05 Million

Check Enzo Biochem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enzo Biochem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 215.2 K or Total Revenue of 63.1 M, as well as many indicators such as Price To Sales Ratio of 1.99, Dividend Yield of 2.0E-4 or PTB Ratio of 1.13. Enzo financial statements analysis is a perfect complement when working with Enzo Biochem Valuation or Volatility modules.
  
Check out the analysis of Enzo Biochem Correlation against competitors.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Enzo Biochem Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets100.6 M98.6 M93.3 M
Slightly volatile
Short and Long Term Debt Total3 M3.2 M10.4 M
Pretty Stable
Other Current Liabilities27.2 M25.9 M12.6 M
Slightly volatile
Total Current Liabilities15.1 M28.5 M22.5 M
Slightly volatile
Total Stockholder Equity74.8 M64.5 M61.8 M
Slightly volatile
Property Plant And Equipment Net12.5 M17.5 M14.9 M
Slightly volatile
Cash42.5 M60.2 M42.8 M
Slightly volatile
Non Current Assets Total32 M18.1 M26.2 M
Pretty Stable
Non Currrent Assets Other453.1 K477 K1.7 M
Slightly volatile
Cash And Short Term Investments46.6 M60.2 M45 M
Slightly volatile
Net Receivables4.4 M4.6 M9.6 M
Slightly volatile
Common Stock Shares Outstanding37.4 M58.5 M44.4 M
Slightly volatile
Liabilities And Stockholders Equity100.6 M98.6 M93.3 M
Slightly volatile
Non Current Liabilities Total7.8 M4.4 M8.8 M
Pretty Stable
Inventory5.6 M7.9 M8 M
Pretty Stable
Other Current Assets8.3 M7.9 M3.9 M
Slightly volatile
Other Stockholder Equity220 M400.4 M306.9 M
Slightly volatile
Total Liabilities18.8 M26.7 M30.6 M
Very volatile
Property Plant And Equipment Gross38.6 M36.8 M21.8 M
Slightly volatile
Total Current Assets68.6 M80.5 M67.1 M
Slightly volatile
Intangible Assets6.7 M6.7 M5.3 M
Very volatile
Accounts Payable1.5 M1.6 M6.3 M
Slightly volatile
Short Term Debt784 K825.3 K2.5 M
Very volatile
Common Stock Total Equity422.6 K560 K449.3 K
Slightly volatile
Common Stock433.3 K599.1 K455.3 K
Slightly volatile
Other Liabilities4.3 K4.5 K560.7 K
Slightly volatile
Other Assets6.3 M6 M2.6 M
Slightly volatile
Good Will8.5 M6.7 M7.5 M
Pretty Stable
Property Plant Equipment10.2 M19.2 M12.7 M
Slightly volatile
Long Term Debt206.5 K217.3 K1.3 M
Pretty Stable
Net Tangible Assets58.6 M90.2 M56 M
Slightly volatile
Capital Surpluse359.7 M396.1 M333.1 M
Slightly volatile
Non Current Liabilities Other15.4 M14.7 M5.9 M
Slightly volatile
Short and Long Term Debt65 K68.4 K1.9 M
Slightly volatile
Long Term Debt Total293.9 K309.4 K1.5 M
Pretty Stable
Capital Lease Obligations3.5 M3.7 M4.8 M
Slightly volatile
Cash And Equivalents41.7 M74.1 M59.7 M
Pretty Stable
Net Invested Capital60 M50.7 M77.7 M
Slightly volatile
Net Working Capital41.4 M40.7 M57.7 M
Slightly volatile
Capital Stock537.3 K599.1 K491.2 K
Slightly volatile

Enzo Biochem Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.5 M1.5 M2.9 M
Slightly volatile
Total Revenue63.1 M36.7 M78.6 M
Pretty Stable
Gross Profit31.5 M16.8 M33.2 M
Slightly volatile
Other Operating Expenses70.6 M50.9 M88.7 M
Pretty Stable
Cost Of Revenue31.5 M19.9 M45.4 M
Pretty Stable
Total Operating Expenses39 M31 M43.4 M
Pretty Stable
Research Development4.2 M2.4 M3.5 M
Pretty Stable
Selling General Administrative39.7 M28 M39.9 M
Pretty Stable
Selling And Marketing Expenses3.2 M3 M910.7 K
Slightly volatile
Interest Income4.3 M4.1 M1.5 M
Slightly volatile
Reconciled Depreciation2.2 M1.1 M2.9 M
Slightly volatile
Extraordinary Items54.7 M52.1 M13.4 M
Slightly volatile
Discontinued Operations54.7 M52.1 M13.9 M
Slightly volatile

Enzo Biochem Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow100.7 M95.9 M45.9 M
Slightly volatile
Depreciation2.7 M1.5 M2.9 M
Slightly volatile
Capital Expenditures466 K490.5 K2.6 M
Pretty Stable
End Period Cash Flow41.6 M60.2 M41.6 M
Slightly volatile
Stock Based Compensation2.1 M2.1 M1.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.992.092.8676
Slightly volatile
Dividend Yield2.0E-42.0E-43.0E-4
Slightly volatile
PTB Ratio1.131.192.6198
Slightly volatile
Days Sales Outstanding10352.4651.8427
Very volatile
Book Value Per Share2.21.271.4223
Slightly volatile
Stock Based Compensation To Revenue0.0680.06480.0317
Slightly volatile
Capex To Depreciation0.470.492.5707
Slightly volatile
PB Ratio1.131.192.6198
Slightly volatile
Inventory Turnover2.162.285.4017
Slightly volatile
Days Of Inventory On Hand85.6916682.038
Slightly volatile
Payables Turnover6.3411.37.8185
Slightly volatile
Sales General And Administrative To Revenue0.440.690.5294
Slightly volatile
Research And Ddevelopement To Revenue0.09990.09520.0565
Slightly volatile
Capex To Revenue0.01870.01960.0737
Slightly volatile
Cash Per Share1.451.181.1066
Very volatile
Payout Ratio0.01120.01260.0137
Slightly volatile
Days Payables Outstanding60.6833.4352.261
Slightly volatile
Intangibles To Total Assets0.130.070.1238
Slightly volatile
Current Ratio3.093.254.5353
Slightly volatile
Tangible Book Value Per Share1.260.991.1563
Slightly volatile
Receivables Turnover4.497.28.6342
Very volatile
Graham Number2.783.213.516
Very volatile
Shareholders Equity Per Share2.21.271.4223
Slightly volatile
Debt To Equity0.06830.07190.2541
Slightly volatile
Capex Per Share0.01170.01230.0806
Slightly volatile
Revenue Per Share0.540.561.6854
Slightly volatile
Interest Debt Per Share0.07950.08370.4584
Slightly volatile
Debt To Assets0.04470.04710.1171
Slightly volatile
Operating Cycle189218134
Slightly volatile
Price Book Value Ratio1.131.192.6198
Slightly volatile
Days Of Payables Outstanding60.6833.4352.261
Slightly volatile
Dividend Payout Ratio0.01120.01260.0137
Slightly volatile
Ebt Per Ebit0.960.911.0385
Slightly volatile
Company Equity Multiplier3.041.761.7328
Very volatile
Long Term Debt To Capitalization0.00370.00390.0658
Slightly volatile
Total Debt To Capitalization0.06430.06770.1444
Slightly volatile
Debt Equity Ratio0.06830.07190.2541
Slightly volatile
Quick Ratio2.782.934.146
Slightly volatile
Cash Ratio2.312.433.408
Slightly volatile
Cash Conversion Cycle13118585.6218
Slightly volatile
Days Of Inventory Outstanding85.6916682.038
Slightly volatile
Days Of Sales Outstanding10352.4651.8427
Very volatile
Price To Book Ratio1.131.192.6198
Slightly volatile
Fixed Asset Turnover1.791.896.9173
Slightly volatile
Debt Ratio0.04470.04710.1171
Slightly volatile
Price Sales Ratio1.992.092.8676
Slightly volatile
Asset Turnover0.50.330.8807
Slightly volatile
Gross Profit Margin0.610.530.4553
Pretty Stable
Price Fair Value1.131.192.6198
Slightly volatile

Enzo Biochem Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap49.6 M52.2 M126.5 M
Slightly volatile
Enterprise Value7.8 M8.2 M76.4 M
Slightly volatile

Enzo Fundamental Market Drivers

Cash And Short Term Investments52.4 M

Enzo Upcoming Events

18th of March 2024
Upcoming Quarterly Report
View
31st of January 2024
Next Fiscal Quarter End
View

About Enzo Biochem Financial Statements

Enzo Biochem investors use historical fundamental indicators, such as Enzo Biochem's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Enzo Biochem. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue6.8 M3.7 M
Total Revenue36.7 M63.1 M
Cost Of Revenue19.9 M31.5 M
Stock Based Compensation To Revenue 0.06  0.07 
Sales General And Administrative To Revenue 0.69  0.44 
Research And Ddevelopement To Revenue 0.10  0.10 
Capex To Revenue 0.02  0.02 
Revenue Per Share 0.56  0.54 
Ebit Per Revenue(0.35)(0.34)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CRMSalesforce
CCitigroup
GMGeneral Motors

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY